Literature DB >> 25313318

Development of a new benzophenone-diketopiperazine-type potent antimicrotubule agent possessing a 2-pyridine structure.

Yoshiki Hayashi1, Haruka Takeno1, Takumi Chinen2, Kyohei Muguruma1, Kohei Okuyama3, Akihiro Taguchi1, Kentaro Takayama1, Fumika Yakushiji1, Masahiko Miura4, Takeo Usui2, Yoshio Hayashi1.   

Abstract

A new benzophenone-diketopiperazine-type potent antimicrotubule agent was developed by modifying the structure of the clinical candidate plinabulin (1). Although the right-hand imidazole ring with a branched alkyl chain at the 5-position in 1 was critical for the potency of the antimicrotubule activity, we successfully substituted this moiety with a simpler 2-pyridyl structure by converting the left-hand ring from a phenyl to a benzophenone structure without decreasing the potency. The resultant compound 6b (KPU-300) exhibited a potent cytotoxicity, with an IC50 value of 7.0 nM against HT-29 cells, by strongly binding to tubulin (K d = 1.3 μM) and inducing microtubule depolymerization.

Entities:  

Keywords:  Cyclic dipeptide; anticancer; antimicrotubule agent; diketopiperazine

Year:  2014        PMID: 25313318      PMCID: PMC4190642          DOI: 10.1021/ml5001883

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  19 in total

1.  Synthesis and biological activities of phenylahistin derivatives.

Authors:  K Kanoh; S Kohno; J Katada; J Takahashi; I Uno; Y Hayashi
Journal:  Bioorg Med Chem       Date:  1999-07       Impact factor: 3.641

2.  Total synthesis of anti-microtubule diketopiperazine derivatives: phenylahistin and aurantiamine.

Authors:  Y Hayashi; S Orikasa; K Tanaka; K Kanoh; Y Kiso
Journal:  J Org Chem       Date:  2000-12-01       Impact factor: 4.354

Review 3.  Vascular disrupting agents (VDAs) in anticancer therapy.

Authors:  Laura G M Daenen; Jeanine M L Roodhart; Yuval Shaked; Emile E Voest
Journal:  Curr Clin Pharmacol       Date:  2010-08

4.  Synthesis and structure-activity relationships of benzophenone-bearing diketopiperazine-type anti-microtubule agents.

Authors:  Yuri Yamazaki; Makiko Sumikura; Yurika Masuda; Yoshiki Hayashi; Hiroyuki Yasui; Yoshiaki Kiso; Takumi Chinen; Takeo Usui; Fumika Yakushiji; Barbara Potts; Saskia Neuteboom; Michael Palladino; George Kenneth Lloyd; Yoshio Hayashi
Journal:  Bioorg Med Chem       Date:  2012-06-04       Impact factor: 3.641

Review 5.  Paclitaxel in cancer therapy.

Authors:  Tarek M Mekhail; Maurie Markman
Journal:  Expert Opin Pharmacother       Date:  2002-06       Impact factor: 3.889

6.  Synthesis and structure-activity relationship study of antimicrotubule agents phenylahistin derivatives with a didehydropiperazine-2,5-dione structure.

Authors:  Yuri Yamazaki; Koji Tanaka; Benjamin Nicholson; Gordafaried Deyanat-Yazdi; Barbara Potts; Tomoko Yoshida; Akiko Oda; Takayoshi Kitagawa; Sumie Orikasa; Yoshiaki Kiso; Hiroyuki Yasui; Miki Akamatsu; Takumi Chinen; Takeo Usui; Yuki Shinozaki; Fumika Yakushiji; Brian R Miller; Saskia Neuteboom; Michael Palladino; Kaneo Kanoh; George Kenneth Lloyd; Yoshio Hayashi
Journal:  J Med Chem       Date:  2012-01-20       Impact factor: 7.446

Review 7.  The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics.

Authors:  E K Rowinsky; R C Donehower
Journal:  Pharmacol Ther       Date:  1991-10       Impact factor: 12.310

Review 8.  Disrupting tumour blood vessels.

Authors:  Gillian M Tozer; Chryso Kanthou; Bruce C Baguley
Journal:  Nat Rev Cancer       Date:  2005-06       Impact factor: 60.716

9.  Antitumor activity of phenylahistin in vitro and in vivo.

Authors:  K Kanoh; S Kohno; J Katada; Y Hayashi; M Muramatsu; I Uno
Journal:  Biosci Biotechnol Biochem       Date:  1999-06       Impact factor: 2.043

Review 10.  Microtubule-binding agents: a dynamic field of cancer therapeutics.

Authors:  Charles Dumontet; Mary Ann Jordan
Journal:  Nat Rev Drug Discov       Date:  2010-10       Impact factor: 84.694

View more
  5 in total

Review 1.  Benzophenone: a ubiquitous scaffold in medicinal chemistry.

Authors:  Khemchand Surana; Bharatkumar Chaudhary; Monika Diwaker; Satyasheel Sharma
Journal:  Medchemcomm       Date:  2018-08-23       Impact factor: 3.597

2.  Synthesis of monoalkylidene diketopiperazines and application to the synthesis of barettin.

Authors:  Elizabeth W Kelley; Skylar G Norman; Jonathan R Scheerer
Journal:  Org Biomol Chem       Date:  2017-10-18       Impact factor: 3.876

3.  KPU-300, a Novel Benzophenone-Diketopiperazine-Type Anti-Microtubule Agent with a 2-Pyridyl Structure, Is a Potent Radiosensitizer That Synchronizes the Cell Cycle in Early M Phase.

Authors:  Kohei Okuyama; Atsushi Kaida; Yoshiki Hayashi; Yoshio Hayashi; Kiyoshi Harada; Masahiko Miura
Journal:  PLoS One       Date:  2015-12-30       Impact factor: 3.240

4.  Biological activity and interaction mechanism of the diketopiperazine derivatives as tubulin polymerization inhibitors.

Authors:  Zhenhua Tian; Yanyan Chu; Hui Wang; Lili Zhong; Mengyan Deng; Wenbao Li
Journal:  RSC Adv       Date:  2018-01-03       Impact factor: 4.036

5.  Metal-Dependent Cytotoxic and Kinesin Spindle Protein Inhibitory Activity of Ru, Os, Rh, and Ir Half-Sandwich Complexes of Ispinesib-Derived Ligands.

Authors:  Michał Łomzik; Muhammad Hanif; Aleksandra Budniok; Andrzej Błauż; Anna Makal; Daniel M Tchoń; Barbara Leśniewska; Kelvin K H Tong; Sanam Movassaghi; Tilo Söhnel; Stephen M F Jamieson; Ayesha Zafar; Jóhannes Reynisson; Błażej Rychlik; Christian G Hartinger; Damian Plażuk
Journal:  Inorg Chem       Date:  2020-10-01       Impact factor: 5.165

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.